Reduced Brain Cannabinoid Receptor Availability In Schizophrenia

BACKGROUND: Several lines of evidence suggest the presence of abnormalities in the endocannabinoid (eCB) system in schizophrenia (SCZ). However, there are limited in vivo measures of the eCB system in SCZ. METHODS: Twenty five male SCZ subjects (SCZs), 18 antipsychotic treated [SCZ-MED] and 7 antips...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biol Psychiatry
Egile Nagusiak: Ranganathan, Mohini, Cortes, Jose, Radhakrishnan, Rajiv, Thurnauer, Halle, Planeta, Beata, Skosnik, Patrick, Gao, Hong, Labaree, David, Neumeister, Alexander, Pittman, Brian, Surti, Toral, Huang, Yiyun, Carson, Richard E., D’Souza, Deepak Cyril
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884543/
https://ncbi.nlm.nih.gov/pubmed/26432420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2015.08.021
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak